Home | Welcome to Contract Pharma   
Last Updated Friday, May 22 2015

Print RSS Feed

Breaking News

January 19, 2015
Adds expertise for high potency and cytotoxic drugs in the U.S.  Read More »
January 16, 2015
Protocol noncompliance is the fastest growing performance deficiency  Read More »
January 16, 2015
Gains NUCYNTA product rights for $1.05 billion  Read More »
January 16, 2015
Gains Funding from Innovative Medicines Initiative   Read More »
January 15, 2015
Will conduct influenza challenge research at WCCT's Costa Mesa facility   Read More »
January 15, 2015
Terhaerdt to head direction of drug development ops in The Netherlands and U.S.  Read More »
January 15, 2015
Validates recently expanded facility in Irvine, Scotland  Read More »
January 15, 2015
Sanofi gains access to capabilities to transfer and manufacture biologics  Read More »
January 15, 2015
Will apply Catalent’s SMARTag technology in Sanofi’s antibodies  Read More »
January 14, 2015
Gains exclusive rights to oncology target  Read More »
January 14, 2015
Gains exclusive rights to Phase III immuno-oncology compound  Read More »
January 14, 2015
Validates MSD V-PLEX 10-plex Proinflammatory Panel  Read More »
January 14, 2015
Gaspar to lead Lisbon and New Jersey teams  Read More »
January 13, 2015
ready-to-use pharma vials will be available for purchase in early 2015  Read More »
January 13, 2015
To evaluate nivolumab in combination with Lilly’s galunisertib  Read More »



Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On